varenicline pfizer
pfizer new zealand limited - varenicline tartrate 1.71mg equivalent to 1 mg varenicline; ; - film coated tablet - 1 mg - active: varenicline tartrate 1.71mg equivalent to 1 mg varenicline excipient: calcium hydrogen phosphate colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose opadry blue 03b90547 opadry clear ys-2-19114-a - an aid to smoking cessation
varenicline pfizer 0.5 mg and 1 mg tablets
pfizer new zealand limited - varenicline tartrate 0.85mg equivalent to 0.5 mg varenicline; ; ; varenicline tartrate 1.71mg equivalent to 1 mg varenicline - combination - 0.5 mg and 1 mg - active: varenicline tartrate 0.85mg equivalent to 0.5 mg varenicline excipient: calcium hydrogen phosphate colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose opadry clear ys-2-19114-a opadry white ys-1-18202 active: varenicline tartrate 1.71mg equivalent to 1 mg varenicline excipient: calcium hydrogen phosphate colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose opadry blue 03b90547 opadry clear ys-2-19114-a - an aid to smoking cessation
premia 2.5 continuous
pfizer new zealand limited - conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.); ; medroxyprogesterone acetate 2.6mg (includes 4% overage.); conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.); medroxyprogesterone acetate 2.6mg (includes 4% overage.) - tablet - active: conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.) medroxyprogesterone acetate 2.6mg (includes 4% overage.) excipient: calcium sulfate carnauba wax glyceryl mono-oleate iron oxide red lactose monohydrate macrogol 20000 magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide active: conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.) medroxyprogesterone acetate 2.6mg (includes 4% overage.) excipient: calcium sulfate carnauba wax glyceryl mono-oleate iron oxide red lactose monohydrate macrogol 20000 magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide
premia 5 continuous
pfizer new zealand limited - conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.); ; medroxyprogesterone acetate 5mg (includes 4% overage); conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.); medroxyprogesterone acetate 5mg (includes 4% overage) - tablet - active: conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.) medroxyprogesterone acetate 5mg (includes 4% overage) excipient: calcium sulfate carnauba wax glyceryl mono-oleate iron oxide red lactose monohydrate macrogols magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide active: conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.) medroxyprogesterone acetate 5mg (includes 4% overage) excipient: calcium sulfate carnauba wax glyceryl mono-oleate indigo carmine lactose monohydrate macrogols magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide
duavive
pfizer new zealand limited - bazedoxifene acetate 22.56mg equivalent to 20mg bazedoxifene - in tablet subcoat; ; conjugated estrogens 0.45mg (10.4895 mg conjugated estrogens (ce) dessication with lactose (containing 4.29% ce) - in tablet core); - modified release tablet - 0.45mg/20mg - active: bazedoxifene acetate 22.56mg equivalent to 20mg bazedoxifene - in tablet subcoat conjugated estrogens 0.45mg (10.4895 mg conjugated estrogens (ce) dessication with lactose (containing 4.29% ce) - in tablet core) excipient: ascorbic acid hyprolose hypromellose isopropyl alcohol lactose monohydrate macrogol 400 magnesium stearate microcrystalline cellulose opacode black ns-78-17821 opadry pink 03b14899 opaglos clear 98z19173 purified water sucrose sucrose palmitate - duavive is indicated for treatment of oestrogen deficiency symptoms in postmenopausal women with a uterus (with at least 12 months since the last menses) for whom treatment with progestin-containing therapy is not appropriate. the experience treating women older than 65 years is limited.
tygacil
pfizer new zealand limited - tigecycline 50mg (plus a 6% overage to compensate for losses during reconsitution and withdrawal); - powder for injection - 50 mg - active: tigecycline 50mg (plus a 6% overage to compensate for losses during reconsitution and withdrawal) excipient: lactose monohydrate - tygacil is indicated for the treatment of the following infections in adults: · complicated skin and skin structure infections, including those with methicillin-resistant staphylococcus aureus (mrsa), where there is suspected or proven resistance to, intolerance of, or there are co-morbidities preventing the use of, other available agents. · complicated intra-abdominal infections, where there is suspected or proven resistance to, intolerance of, or there are co-morbidities preventing the use of, other available agents.
edronax
pfizer new zealand limited - reboxetine mesilate 5.224mg equivalent to 4 mg reboxetine free base - tablet - 4 mg - active: reboxetine mesilate 5.224mg equivalent to 4 mg reboxetine free base excipient: calcium hydrogen phosphate dihydrate crospovidone hydrated silica magnesium stearate powdered cellulose
lincocin
pfizer new zealand limited - lincomycin hydrochloride monohydrate 340.26 mg/ml equivalent to lincomycin 300 mg/ml - solution for injection - 300 mg/ml - active: lincomycin hydrochloride monohydrate 340.26 mg/ml equivalent to lincomycin 300 mg/ml excipient: benzyl alcohol water for injection
heparin sodium (pfizer)
pfizer new zealand limited - heparin sodium 5000 iu/ml; - solution for injection - 25000 iu/5ml - active: heparin sodium 5000 iu/ml excipient: hydrochloric acid sodium hydroxide water for injection
heparin sodium (pfizer)
pfizer new zealand limited - heparin sodium 1000 iu/ml; - solution for injection - 5000 iu/5ml - active: heparin sodium 1000 iu/ml excipient: hydrochloric acid sodium hydroxide water for injection